0001209191-22-008948.txt : 20220211 0001209191-22-008948.hdr.sgml : 20220211 20220211173321 ACCESSION NUMBER: 0001209191-22-008948 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220211 DATE AS OF CHANGE: 20220211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scopa James Paul CENTRAL INDEX KEY: 0001356950 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40794 FILM NUMBER: 22623031 MAIL ADDRESS: STREET 1: 601 GATEWAY BOULEVARD STREET 2: SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DICE Therapeutics, Inc. CENTRAL INDEX KEY: 0001645569 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472286244 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 279 E. GRAND AVENUE, SUITE 300, LOBBY B CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-566-1402 MAIL ADDRESS: STREET 1: 279 E. GRAND AVENUE, SUITE 300, LOBBY B CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: DiCE MOLECULES HOLDINGS, LLC DATE OF NAME CHANGE: 20180725 FORMER COMPANY: FORMER CONFORMED NAME: DiCE Molecules Holdings, LLC DATE OF NAME CHANGE: 20150617 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2021-12-31 0 0 0 0001645569 DICE Therapeutics, Inc. DICE 0001356950 Scopa James Paul C/O DICE THERAPEUTICS, INC. 279 E. GRAND AVENUE, SUITE 300, LOBBY B SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2021-12-30 5 G 0 3000 0.00 D 52841 D Common Stock 2021-12-30 5 G 0 3000 0.00 A 3000 I By Trust Represents shares of the Issuer's Common Stock that the Reporting Person transferred as a bona fide gift for no consideration, which shares have not been sold and remain subject to the lock-up agreement entered into in connection with the Issuer's initial public offering. These securities are held of record by The James P. Scopa and Anne E. Kenner Family Trust, Anne E. Kenner and James P. Scopa, Trustees. /s/ Scott Robertson as attorney-in-fact for James P. Scopa 2022-02-11